TVTX Travere Therapeutics, Inc.

track record → $38.78 -1.51 (-3.8%)
Get emailed when TVTX changes direction
Mkt Cap $4B 52wk $13.88 - $43.31 Earnings 2026-04-30
Factor Model (net -2.9)

Factor Model

net -2.9
Est. Revisions
-1.0
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
-1.0
Narrative Gap
+0.0

Analysis pending — waiting for first signal cycle.

Evidence

1d ago Travere Therapeutics (TVTX) Climbs 40.8% on Filspari Approval yahoo-finance
41d ago Piper Sandler Increases Target Price for Travere Therapeutics (TVTX) yahoo-finance
59d ago Travere Therapeutics Q4 Earnings Call Highlights yahoo-finance
Fundamentals & Data ▾
Travere Therapeutics, Inc. Healthcare · Biotechnology
Mkt Cap
$4B
Beta
0.87
52w Range
$13.88 - $43.31
Short Interest
13.4M 19.07%
Days to Cover
10.9 -5%
Technicals downtrend
from 52w Hi
-8.0%
1w return
-8.0%
EPS Estimate
$-0.05 -299.0% 30d 0up / 2dn
Est. Dispersion
848% 6 analysts
Analyst Target
$48 $40 - $56
Options P/C
2.81
Fund Convergence
strong Renaissance, D.E. Shaw, Two Sigma, Citadel
Financials
Revenue
$130M +73% YoY
FCF
$42M
Gross Margin
98%
Op Margin
-25%
Momentum: decelerating
Top Holders
Renaissance $86M
D.E. Shaw $31M
Two Sigma $28M
Citadel $12M
3 signals · latest 1d ago

Get alerted when TVTX changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.

All stocks → Our calls → How it works →